CD34 (+) cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina

Patients with refractory angina who are suboptimal candidates for further revascularization have improved exercise time, decreased angina frequency, and reduced major adverse cardiac events with intramyocardial delivery of CD34(+) cells. However, the effect of CD34(+) cell therapy on health care exp...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Stem Cells Transl Med
Hlavní autoři: Johnson, Grace L., Henry, Timothy D., Povsic, Thomas J., Losordo, Douglas W., Garberich, Ross F., Stanberry, Larissa I., Strauss, Craig E., Traverse, Jay H.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Inc. 2020
Témata:
Human Clinical Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7519768/
https://ncbi.nlm.nih.gov/pubmed/32531108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.20-0046
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky